James Hambro & Partners LLP Has $109.60 Million Stock Position in Synopsys, Inc. $SNPS

Key Points

• James Hambro & Partners LLP increased its stake in Synopsys, Inc. by 4.4%, owning 213,673 shares valued at approximately $109.6 million, representing 4.3% of its portfolio.
• Institutional investors own 85.47% of Synopsys's stock, highlighting significant interest from large investment firms.
• Analyst price targets for Synopsys have been cut recently, with Morgan Stanley reducing its target from $715 to $510, indicating a bearish outlook on the company's stock.

James Hambro & Partners LLP grew its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 4.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 213,673 shares of the semiconductor company's stock after buying an additional 9,093 shares during the period. Synopsys makes up 4.3% of James Hambro & Partners LLP's portfolio, making the stock its 13th largest position. James Hambro & Partners LLP owned approximately 0.14% of Synopsys worth $109,600,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC boosted its stake in Synopsys by 54,286.0% in the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company's stock worth $513,116,000 after purchasing an additional 1,194,292 shares during the period. Nuveen LLC acquired a new position in Synopsys in the 1st quarter worth $341,480,000. Pictet Asset Management Holding SA boosted its stake in Synopsys by 38.3% in the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock worth $1,043,518,000 after purchasing an additional 673,837 shares during the period. Generation Investment Management LLP acquired a new position in Synopsys in the 1st quarter worth $240,491,000. Finally, Vanguard Group Inc. boosted its stake in Synopsys by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company's stock worth $6,359,747,000 after purchasing an additional 346,994 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Up 0.1%

Synopsys stock opened at $487.76 on Friday. The stock has a market cap of $90.60 billion, a P/E ratio of 38.29, a P/E/G ratio of 5.51 and a beta of 1.14. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company's 50-day moving average price is $571.71 and its two-hundred day moving average price is $508.57.

Wall Street Analyst Weigh In

SNPS has been the topic of several analyst reports. Morgan Stanley cut their price target on shares of Synopsys from $715.00 to $510.00 and set an "overweight" rating on the stock in a research report on Thursday, September 11th. Wells Fargo & Company cut their price target on shares of Synopsys from $630.00 to $550.00 and set an "equal weight" rating on the stock in a research report on Wednesday, September 10th. Baird R W cut shares of Synopsys from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 10th. Robert W. Baird reissued a "neutral" rating and set a $535.00 price target (down from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Bank of America reissued an "underperform" rating and set a $525.00 price target (down from $625.00) on shares of Synopsys in a research report on Wednesday, September 10th. Eleven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, Synopsys has a consensus rating of "Hold" and a consensus target price of $585.33.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the transaction, the chief financial officer owned 15,317 shares in the company, valued at $9,339,847.09. This represents a 19.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the transaction, the chief executive officer owned 71,615 shares in the company, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 30,894 shares of company stock worth $16,760,783. 0.62% of the stock is currently owned by company insiders.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.